Classification of first-episode psychosis in a large cohort of patients using support vector machine and multiple kernel learning techniques.

Journal: NeuroImage
Published Date:

Abstract

First episode psychosis (FEP) patients are of particular interest for neuroimaging investigations because of the absence of confounding effects due to medications and chronicity. Nonetheless, imaging data are prone to heterogeneity because for example of age, gender or parameter setting differences. With this work, we wanted to take into account possible nuisance effects of age and gender differences across dataset, not correcting the data as a pre-processing step, but including the effect of nuisance covariates in the classification phase. To this aim, we developed a method which, based on multiple kernel learning (MKL), exploits the effect of these confounding variables with a subject-depending kernel weighting procedure. We applied this method to a dataset of cortical thickness obtained from structural magnetic resonance images (MRI) of 127 FEP patients and 127 healthy controls, who underwent either a 3Tesla (T) or a 1.5T MRI acquisition. We obtained good accuracies, notably better than those obtained with standard SVM or MKL methods, up to more than 80% for frontal and temporal areas. To our best knowledge, this is the largest classification study in FEP population, showing that fronto-temporal cortical thickness can be used as a potential marker to classify patients with psychosis.

Authors

  • Letizia Squarcina
    UOC Psychiatry, Azienda Ospedaliera Universitaria Integrata Verona (AOUI), Italy; InterUniversity Centre for Behavioural Neurosciences (ICBN), University of Verona, Verona, Italy.
  • Umberto Castellani
    Department of Informatics, University of Verona, Verona, Italy.
  • Marcella Bellani
    UOC Psychiatry, Azienda Ospedaliera Universitaria Integrata Verona (AOUI), Italy; InterUniversity Centre for Behavioural Neurosciences (ICBN), University of Verona, Verona, Italy.
  • Cinzia Perlini
    InterUniversity Centre for Behavioural Neurosciences (ICBN), University of Verona, Verona, Italy; Department of Public Health and Community Medicine, Section of Clinical Psychology, University of Verona, Verona, Italy.
  • Antonio Lasalvia
    UOC Psychiatry, Azienda Ospedaliera Universitaria Integrata Verona (AOUI), Italy.
  • Nicola Dusi
    UOC Psychiatry, Azienda Ospedaliera Universitaria Integrata Verona (AOUI), Italy; InterUniversity Centre for Behavioural Neurosciences (ICBN), University of Verona, Verona, Italy.
  • Chiara Bonetto
    Section of Psychiatry, Department of Neurological, Biomedical and Movement Sciences, University of Verona, Verona, Italy.
  • Doriana Cristofalo
    Section of Psychiatry, Department of Neurological, Biomedical and Movement Sciences, University of Verona, Verona, Italy.
  • Sarah Tosato
    Section of Psychiatry, Department of Neurological, Biomedical and Movement Sciences, University of Verona, Verona, Italy.
  • Gianluca Rambaldelli
    InterUniversity Centre for Behavioural Neurosciences (ICBN), University of Verona, Verona, Italy; Section of Psychiatry, Department of Neurological, Biomedical and Movement Sciences, University of Verona, Verona, Italy.
  • Franco Alessandrini
    Neuroradiology Department, Azienda Ospedaliera Universitaria, Verona, Italy.
  • Giada Zoccatelli
    Neuroradiology Department, Azienda Ospedaliera Universitaria, Verona, Italy.
  • Roberto Pozzi-Mucelli
    Department of Radiology, G.B. Rossi Hospital, University of Verona, Verona, Italy.
  • Dario Lamonaca
    Department of Psychiatry, CSM AULSS 21 Legnago, Verona, Italy.
  • Enrico Ceccato
    Department of Mental Health, Hospital of Montecchio Maggiore, Vicenza, Italy.
  • Francesca Pileggi
    Department of Mental Health, Azienda ULSS Bologna, Bologna, Italy.
  • Fausto Mazzi
    Department of Mental Health, Modena, Italy.
  • Paolo Santonastaso
    Department of Neuroscience, University of Padova, Padova, Italy.
  • Mirella Ruggeri
    UOC Psychiatry, Azienda Ospedaliera Universitaria Integrata Verona (AOUI), Italy; Section of Psychiatry, Department of Neurological, Biomedical and Movement Sciences, University of Verona, Verona, Italy.
  • Paolo Brambilla
    Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy; Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, TX, USA. Electronic address: paolo.brambilla1@unimi.it.